Recommended anchor dose
BPK-201 dose optimization
Candidate active dose160 mg
Backend ready
Dose Optimus Studio compares candidate doses using exposure-response, safety ceilings, information strength, uncertainty gaps, and next-study needs so teams can carry a defensible active-dose set forward.
Programme context stays with you across Innovator · Evidence classes remain explicit · Heavy workflows require confirmation · Do not share identifiable patient data.